共 50 条
- [1] Secukinumab in Active Rheumatoid Arthritis after Anti-TNFα Therapy: A Randomized, Double-Blind Placebo-Controlled Phase 3 StudyRHEUMATOLOGY AND THERAPY, 2017, 4 (02) : 475 - 488Tahir, HasanDeodhar, AtulGenovese, MarkTakeuchi, TsutomuAelion, JacobVan den Bosch, FilipHaemmerle, SibylleRichards, Hanno B.
- [2] Secukinumab in Active Rheumatoid Arthritis: A Phase III Randomized, Double-Blind, Active Comparator- and Placebo-Controlled StudyARTHRITIS & RHEUMATOLOGY, 2017, 69 (06) : 1144 - 1153Blanco, Francisco J.Moericke, RuedigerDokoupilova, EvaCodding, ChristineNeal, JeffreyAndersson, MatsRohrer, SusanneRichards, Hanno
- [3] A double-blind, placebo-controlled, phase II, randomized study of lovastatin therapy in the treatment of mildly active rheumatoid arthritisRHEUMATOLOGY, 2020, 59 (07) : 1505 - 1513Aranow, CynthiaCush, JohnBolster, Marcy B.Striebich, Christopher C.Dall'era, MariaMackay, MegganOlech, EwaFrech, TracyBox, JaneKeating, RichardWasko, Mary ChesterSt Clair, WilliamKivitz, AlanHuang, WeiquangRicketts, PetaGayWelch, BeverlyCallahan, SherrieSpychala, MeaganBoyle, KarenYork, KateKeyes-Elstein, LynetteGoldmuntz, EllenDiamond, BettyDavidson, Anne
- [4] SECUKINUMAB EFFICACY IN ANTI-TNF-NAIVE PATIENTS AND PATIENTS PREVIOUSLY EXPOSED TO ANTI-TNF THERAPY: RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY (MEASURE 2) IN ACTIVE ANKYLOSING SPONDYLITISANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 272 - 272Sieper, J.Braun, J.Baraliakos, X.Baeten, D. L.Dougados, M.Emery, P.Deodhar, A.Porter, B.Andersson, M.Richards, H.
- [5] Randomized, Double-blind, Placebo-controlled, Comparative Study of Human Anti-TNF Antibody Adalimumab in Combination with Methotrexate and Methotrexate Alone in Taiwanese Patients with Active Rheumatoid ArthritisJOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2009, 108 (04) : 310 - 319Chen, Der-YuanChou, Show-JanHsieh, Tsu-YiChen, Yi-HsingChen, Hsin-HuaHsieh, Chia-WeiLan, Joung-Liang
- [6] Treatment of rheumatoid arthritis with ornidazole: a randomized, double-blind, placebo-controlled studyRHEUMATOLOGY INTERNATIONAL, 2006, 26 (12) : 1132 - 1137Ogrendik, Mesut
- [7] Treatment of rheumatoid arthritis with ornidazole: a randomized, double-blind, placebo-controlled studyRheumatology International, 2006, 26 : 1132 - 1137Mesut Ogrendik
- [8] Secukinumab improves active psoriatic arthritis and inhibits radiographic progression: Results of a phase 3 randomized, multicenter, double-blind, placebo-controlled studyJOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S29 - S29Mease, P.McInnes, I. B.Kirkham, B.Kavanaugh, A.Rahman, P.Van Der Heijde, D.Landewe, R.Nash, P.Pricop, L.Yuan, J.Richards, H.Mpofu, S.
- [9] Efficacy and Safety of Sirukumab, an Anti-IL-6 Cytokine Monoclonal Antibody, in Patients with Active Rheumatoid Arthritis Despite Anti-TNF Therapy: Results from a Randomized, Double-Blind, Placebo-Controlled, Global, Phase 3 StudyARTHRITIS & RHEUMATOLOGY, 2016, 68Aletaha, DanielBingham, Clifton, IIITanaka, YoshiyaAgarwal, PrasheenKurrasch, ReginaTak, Paul-PeterPopik, Sharon
- [10] Ustekinumab in Active Psoriatic Arthritis Including Patients Previously Treated with Anti-TNF Agents: Results of a Phase 3, Multicenter, Double-Blind, Placebo-Controlled StudyARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S1080 - S1081Ritchlin, Christopher T.Gottlieb, Alice B.McInnes, Iain B.Puig, LluisRahman, ProtonLi, ShuWang, YuhuaDoyle, Mittie K.Mendelsohn, AlanKavanaugh, Arthur